SKF 106160
Alternative Names: UniFluVaxLatest Information Update: 11 Sep 1996
Price :
$50 *
At a glance
- Originator GlaxoSmithKline
- Class Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 11 Sep 1996 Discontinued-II for Influenza virus infections in USA (Unknown route)
- 29 Nov 1994 Phase-I clinical trials for Influenza virus infections in USA (Unknown route)